NOVOCURE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCRPRNewsWire • 08/05/23
ROSEN, A LONGSTANDING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCRPRNewsWire • 08/03/23
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 08/03/23
NOVOCURE SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCRPRNewsWire • 07/29/23
Lost Money in NovoCure Limited? Gibbs Law Group Investigates Potential Securities Law ViolationsBusiness Wire • 07/28/23
NVCR NOTICE: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCRPRNewsWire • 07/27/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/27/23
INVESTOR DEADLINE NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the FirmAccesswire • 07/26/23
NOVOCURE LIMITED (NASDAQ: NVCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure LimitedPRNewsWire • 07/24/23
Novocure Announces Favorable Independent Data Monitoring Committee Recommendation to Continue Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy in Pancreatic CancerBusiness Wire • 07/21/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the FirmAccesswire • 07/21/23
INVESTOR DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/19/23
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCRPRNewsWire • 07/18/23
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the FirmAccesswire • 07/17/23
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/13/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/12/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/11/23
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCRPRNewsWire • 07/08/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the FirmAccesswire • 07/08/23
NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff CabraserBusiness Wire • 07/03/23